About Colin Jackson
Form D filings for Alucent Biomedical in 2023 list Colin Jackson as executive officer.
Colin Jackson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Colin Jackson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Colin Jackson works with at each company, as listed on that company's latest Form D.
Alucent Biomedical, Inc. · Form D, Apr 20, 2023
JL
Julie Lautt
Director
JC
James Corbett
Director
BK
Bruce Krattenmaker
Executive officer
KW
Kevin Warner
Executive officer
MG
Myles Greenberg
President and director
DF
David Flicek
Director
KK
Katalin Kauser
Executive officer
DP
Daniel Pelak
Director
NP
Nick Pappas
Director
JI
James Isaacson
Executive officer
HH
Henry Hauser
Executive officer